General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information...

25
file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22] General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ISIN INE901L01018 Name of the company ALEMBIC PHARMACEUTICALS LIMITED Whether company is SME No Class of Security Equity Shares Type of report Quarterly Quarter Ended / Half year ended/Date of Report (For Prelisting / Allotment) 30-09-2019 Date of allotment / extinguishment (in case Capital Restructuring selected) / Listing Date Shareholding pattern filed under Regulation 31 (1) (b) Declaration Sr. No. Particular Yes/No Promoter and Promoter Group Public shareholder Non Promoter- Non Public 1 Whether the Listed Entity has issued any partly paid up shares? No No No No 2 Whether the Listed Entity has issued any Convertible Securities ? No No No No 3 Whether the Listed Entity has issued any Warrants ? No No No No 4 Whether the Listed Entity has any shares against which depository receipts are issued? No No No No 5 Whether the Listed Entity has any shares in locked-in? No No No No 6 Whether any shares held by promoters are pledge or otherwise encumbered? No No 7 Whether company has equity shares with differential voting rights? No No No No 8 Whether the listed entity has any significant beneficial owner? Yes Table I - Summary Statement holding of specified securities Category (I) Category of shareholder (II) Nos. Of shareholders (III) No. of fully paid up equity shares held (IV) No. Of Partly paid- up equity shares held (V) No. Of shares underlying Depository Receipts (VI) Total nos. shares held (VII) = (IV)+(V)+ (VI) Shareholding as a % of total no. of shares (calculated as per SCRR, 1957) (VIII) As a % of (A+B+C2) Number of Voting Rights held in each class of securities (IX) No of Voting (XIV) Rights Total as a % of (A+B+C) Class eg: X Class eg:y Total (A) Promoter & Promoter 23 137559673 137559673 72.97 137559673 137559673 72.97

Transcript of General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information...

Page 1: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

General information about company

Scrip code 533573

NSE Symbol APLLTD

MSEI Symbol NOTLISTED

ISIN INE901L01018

Name of the company ALEMBIC PHARMACEUTICALSLIMITED

Whether company is SME No

Class of Security Equity Shares

Type of report Quarterly

Quarter Ended / Half year ended/Date of Report (For Prelisting / Allotment) 30-09-2019

Date of allotment / extinguishment (in case Capital Restructuring selected) / ListingDate

Shareholding pattern filed under Regulation 31 (1) (b)

Declaration

Sr.No. Particular Yes/No Promoter and

Promoter GroupPublic

shareholderNon Promoter-

Non Public

1 Whether the Listed Entity has issued any partly paid up shares? No No No No

2 Whether the Listed Entity has issued any ConvertibleSecurities ? No No No No

3 Whether the Listed Entity has issued any Warrants ? No No No No

4 Whether the Listed Entity has any shares against whichdepository receipts are issued? No No No No

5 Whether the Listed Entity has any shares in locked-in? No No No No

6 Whether any shares held by promoters are pledge or otherwiseencumbered? No No

7 Whether company has equity shares with differential votingrights? No No No No

8 Whether the listed entity has any significant beneficial owner? Yes

Table I - Summary Statement holding of specified securities

Category(I)

Categoryofshareholder(II)

Nos. Ofshareholders(III)

No. offully paidup equitysharesheld (IV)

No.OfPartlypaid-upequitysharesheld(V)

No. OfsharesunderlyingDepositoryReceipts(VI)

Total nos.shares held(VII) =(IV)+(V)+(VI)

Shareholdingas a % of totalno. of shares(calculated asper SCRR,1957) (VIII)As a % of(A+B+C2)

Number of Voting Rights held in eachclass of securities (IX)

No of Voting (XIV) Rights

Total asa % of(A+B+C)

Class eg:X

Classeg:y Total

(A)

Promoter&Promoter 23 137559673 137559673 72.97 137559673 137559673 72.97

Page 2: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

Group

(B) Public 42330 50956241 50956241 27.03 50956241 50956241 27.03

(C)NonPromoter-Non Public

(C1)SharesunderlyingDRs

(C2)

Sharesheld byEmployeeTrusts

Total 42353 188515914 188515914 100 188515914 188515914 100

Table I - Summary Statement holding of specified securities

Category(I)

Categoryofshareholder(II)

No. OfSharesUnderlyingOutstandingconvertiblesecurities(X)

No. ofSharesUnderlyingOutstandingWarrants(Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities andNo. OfWarrants (Xi)(a)

Shareholding , as a %assuming fullconversion ofconvertible securities (as a percentage ofdiluted share capital)(XI)= (VII)+(X) As a% of (A+B+C2)

Number ofLocked inshares (XII)

Number ofSharespledged orotherwiseencumbered(XIII)

Number ofequity sharesheld indematerializedform (XIV)

No.(a)

As a% oftotalSharesheld(b)

No.(a)

As a% oftotalSharesheld(b)

(A)

Promoter&PromoterGroup

72.97 137559673

(B) Public 27.03 48997715

(C)NonPromoter-Non Public

(C1)SharesunderlyingDRs

(C2)

Shares heldbyEmployeeTrusts

Total 100 186557388

Table II - Statement showing shareholding pattern of the Promoter and Promoter Group

Sr.Category &Name of theShareholders (I)

Nos. Ofshareholders(III)

No. offully paidup equityshares

No.OfPartlypaid-upequity

No. OfsharesunderlyingDepository

Total nos.sharesheld (VII)=

Shareholdingas a % oftotal no. ofshares(calculatedas per

Number of Voting Rights held in eachclass of securities (IX)

No of Voting (XIV) RightsTotalas a %of

Page 3: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

held (IV) sharesheld(V)

Receipts(VI)

(IV)+(V)+(VI)

SCRR,1957) (VIII)As a % of(A+B+C2)

Class eg: X Classeg:y Total Total

Votingrights

A Table II - Statement showing shareholding pattern of the Promoter and Promoter Group

(1) Indian

(a) Individuals/Hinduundivided Family 8 9663975 9663975 5.13 9663975 9663975 5.13

(d) Any Other(specify) 14 126888718 126888718 67.31 126888718 126888718 67.31

Sub-Total (A)(1) 22 136552693 136552693 72.44 136552693 136552693 72.44

(2) Foreign

(a)

Individuals(NonResidentIndividuals/ForeignIndividuals)

1 1006980 1006980 0.53 1006980 1006980 0.53

Sub-Total (A)(2) 1 1006980 1006980 0.53 1006980 1006980 0.53

Total Shareholding ofPromoter and PromoterGroup (A)=(A)(1)+(A)(2)

23 137559673 137559673 72.97 137559673 137559673 72.97

B Table III - Statement showing shareholding pattern of the Public shareholder

(1) Institutions

(a) Mutual Funds 12 9615185 9615185 5.1 9615185 9615185 5.1

(c) AlternateInvestment Funds 1 71621 71621 0.04 71621 71621 0.04

(e) Foreign PortfolioInvestors 89 17996017 17996017 9.55 17996017 17996017 9.55

(f)FinancialInstitutions/Banks

12 463383 463383 0.25 463383 463383 0.25

(g) InsuranceCompanies 1 1947910 1947910 1.03 1947910 1947910 1.03

(i) Any Other(specify) 1 3250 3250 0 3250 3250 0

Sub-Total (B)(1) 116 30097366 30097366 15.97 30097366 30097366 15.97

( 3 ) Non-institutions

(a(i))

Individuals -i.Individualshareholdersholding nominalshare capital upto Rs. 2 lakhs.

40220 13816711 13816711 7.33 13816711 13816711 7.33

(a(ii))

Individuals - ii.Individualshareholdersholding nominalshare capital inexcess of Rs. 2lakhs.

11 4494417 4494417 2.38 4494417 4494417 2.38

NBFCs

Page 4: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

(b) registered withRBI

3 1235 1235 0 1235 1235 0

(e) Any Other(specify) 1980 2546512 2546512 1.35 2546512 2546512 1.35

Sub-Total (B)(3) 42214 20858875 20858875 11.06 20858875 20858875 11.06

Total PublicShareholding(B)=(B)(1)+(B)(2)+(B)(3)

42330 50956241 50956241 27.03 50956241 50956241 27.03

C Table IV - Statement showing shareholding pattern of the Non Promoter- Non Public shareholder

Total ( A+B+C2 ) 42353 188515914 188515914 100 188515914 188515914 100

Total (A+B+C ) 42353 188515914 188515914 100 188515914 188515914 100

Table II - Statement showing shareholding pattern of the Promoter and Promoter Group

Sr.

No. OfSharesUnderlyingOutstandingconvertiblesecurities(X)

No. ofSharesUnderlyingOutstandingWarrants(Xi)

No. OfSharesUnderlyingOutstandingconvertiblesecuritiesand No. OfWarrants(Xi) (a)

Shareholding ,as a %assuming fullconversion ofconvertiblesecurities ( asa percentageof dilutedshare capital)(XI)=(VII)+(X) Asa % of(A+B+C2)

Number ofLocked inshares (XII)

Number of Sharespledged orotherwiseencumbered (XIII)

Number ofequity sharesheld indematerializedform (XIV)No.

(a)

As a% oftotalSharesheld(b)

No.(a)

As a % oftotal Sharesheld (b)

A Table II - Statement showing shareholding pattern of the Promoter and Promoter Group

(1) Indian

(a) 5.13 9663975

(d) 67.31 126888718

Sub-Total (A)(1) 72.44 136552693

(2) Foreign

(a) 0.53 1006980

Sub-Total (A)(2) 0.53 1006980

Total Shareholding ofPromoter and PromoterGroup (A)=(A)(1)+(A)(2)

72.97 137559673

B Table III - Statement showing shareholding pattern of the Public shareholder

(1) Institutions

(a) 5.1 9615185

(c) 0.04 71621

(e) 9.55 17996017

(f) 0.25 448283

(g) 1.03 1947910

(i) 0 3250

Sub-Total (B)(1) 15.97 30082266

Page 5: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

( 3 ) Non-institutions

(a(i)) 7.33 11886810

(a(ii)) 2.38 4494417

(b) 0 1235

(e) 1.35 2532987

Sub-Total (B)(3) 11.06 18915449

Total PublicShareholding(B)=(B)(1)+(B)(2)+(B)(3)

27.03 48997715

C Table IV - Statement showing shareholding pattern of the Non Promoter- Non Public shareholder

Total ( A+B+C2 ) 100 186557388

Total (A+B+C ) 100 186557388

Disclosure of notes on shareholding pattern TextualInformation(1)

Text Block

Textual Information()

1) In Promoter and Promoter Group - Indian - Individual Category: 10,73,250 Equity Shares held in thename of Chirayu Ramanbhai Amin in representative capacity of Karta of Chirayu Ramanbhai AminHUF. 2) In Promoter and Promoter Group - Indian - Individual Category, Any Other Category - TrustsAND Promoter and Promoter Group - Foreign - Individual Category: Persons and Trusts holding nilequity shares are also shown as member of Promoter Group on the basis of their being also disclosedas part of Promoter Group in the declarations filed under SEBI (Substantial Acquisition of Shares andTakeovers) Regulations, 2011. 3) In Promoter and Promoter Group - Indian - Other Category - BodiesCorporate: The equity shares held by Shreno Limited in the Company are transferred to Nirayu PrivateLimited pursuant to the Order dated 26th July, 2019 passed by the Hon'ble National Company LawTribunal, Ahmedabad Bench in the matter of Composite Scheme of Arrangement between AlembicLimited, Shreno Limited and Nirayu Private Limited. Pending completion of procedural activities forthe change in name of the demat account(s) of Shreno Limited, the equity shares of the Company heldin such demat account are shown under Nirayu Private Limited. Further, Nirayu Private Limited hasbeen converted into a Public Limited company and its name has been changed to Nirayu Limitedpursuant to the Certificate of Incorporation dated 3rd October, 2019 issued by the Registrar ofCompanies, Gujarat in this regard. 4) In Promoter and Promoter Group - Indian - Other Category -Trusts: Virsad Family Trust, Laburnum Family Trust, Laksh Trust, Gallup Trust, Grace Star Trust andSatori Trust are Private Family Trust. The shares are held in the name of the Trustees of the respectiveTrusts.

Individuals/Hindu undivided Family

Searial No. 1 2 3 4 5 6 7

Name of theShareholders (I)

ChirayuRamanbhaiAmin

MalikaChirayu Amin

Pranav ChirayuAmin

ShaunakChirayu Amin

InaayaShaunak Amin

NaintaraShaunak Amin

Ranvir PranavAmin

PAN (II) ABMPA5729P ABMPA5730G ABMPA5731H ABJPA6783G BHYPA9184K ARXPA0076E APDPA2105A

No. of fully paidup equity sharesheld (IV)

4521465 3005730 1009800 1006980 30000 30000 30000

No. Of Partlypaid-up equityshares held (V)

Page 6: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) =(IV)+(V)+ (VI)

4521465 3005730 1009800 1006980 30000 30000 30000

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

2.4 1.59 0.54 0.53 0.02 0.02 0.02

Number of Voting Rights held in each class of securities (IX)

Class eg:X 4521465 3005730 1009800 1006980 30000 30000 30000

Class eg:y

Total 4521465 3005730 1009800 1006980 30000 30000 30000

Total as a % ofTotal Voting rights 2.4 1.59 0.54 0.53 0.02 0.02 0.02

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(Xi)(a) As a% of (A+B+C2)

2.4 1.59 0.54 0.53 0.02 0.02 0.02

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of Shares pledged or otherwise encumbered (XIII)

No. (a)

As a % of totalShares held (b)

Number of equity

Page 7: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

shares held indematerializedform (XIV)

4521465 3005730 1009800 1006980 30000 30000 30000

Reason for not providing PAN

Reason for notproviding PAN

Shareholder type Promoter PromoterGroup Promoter Promoter Promoter

GroupPromoterGroup

PromoterGroup

Individuals/Hindu undivided Family

Searial No. 8 9 10

Name of theShareholders (I) Samira Pranav Amin Barkha Pranav Amin Krupa Shaunak Amin Click here to go back

PAN (II) AIPPA9819C AFKPA3430P AHUPP6264A Total

No. of fully paidup equity sharesheld (IV)

30000 0 0 9663975

No. Of Partlypaid-up equityshares held (V)

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) =(IV)+(V)+ (VI)

30000 0 0 9663975

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

0.02 0 0 5.13

Number of Voting Rights held in each class of securities (IX)

Class eg:X 30000 0 0 9663975

Class eg:y

Total 30000 0 0 9663975

Total as a % ofTotal Voting rights 0.02 0 0 5.13

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlying

Page 8: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

Outstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(Xi)(a) As a% of (A+B+C2)

0.02 0 0 5.13

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of Shares pledged or otherwise encumbered (XIII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

30000 0 0 9663975

Reason for not providing PAN

Reason for notproviding PAN

Shareholder type Promoter Group Promoter Group Promoter Group

Any Other (specify)

Searial No. 1 2 3 4 5 6 7

Category BodiesCorporate

BodiesCorporate

BodiesCorporate

BodiesCorporate

BodiesCorporate

BodiesCorporate Trusts

Name of theShareholders (I)

AlembicLimited Shreno Ltd Nirayu Pvt

LimitedPaushakLimited

Alembic CityLimited

ShrenoPublicationsLimited

VidyanidhiTrust

PAN (II) AABCA7950P AABCA7953Q AAACN7427K AAACD5006G AABCA9411F AAFCA4386B AAATV1633L

No. of theShareholders (I) 1 0 1 1 1 1 0

No. of fully paidup equity sharesheld (IV)

55551528 0 70035435 855 100 100 0

No. Of Partlypaid-up equityshares held (V)

No. Of shares

Page 9: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

underlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) =(IV)+(V)+ (VI)

55551528 0 70035435 855 100 100 0

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

29.47 0 37.15 0 0 0 0

Number of Voting Rights held in each class of securities (IX)

Class eg: X 55551528 0 70035435 855 100 100 0

Class eg:y

Total 55551528 0 70035435 855 100 100 0

Total as a % ofTotal Voting rights 29.47 0 37.15 0 0 0 0

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

29.47 0 37.15 0 0 0 0

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of Shares pledged or otherwise encumbered (XIII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held in

Page 10: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

dematerializedform (XIV)

55551528 0 70035435 855 100 100 0

Reason for not providing PAN

Reason for notproviding PAN

Shareholder type Promoter PromoterGroup

PromoterGroup

PromoterGroup

PromoterGroup

PromoterGroup

PromoterGroup

Any Other (specify)

Searial No. 8 9 10 11 12 13 14

Category Trusts Trusts Trusts Trusts Trusts Trusts Trusts

Name of theShareholders (I)

ArogyavardhiniSociety

UtkarshVidyakendra

UjjwalVidyalaya

Bhailal AminGeneralHospital

UdayEducationSociety

LaburnumFamily Trust

Virsad FamilyTrust

PAN (II) AAATA2302D AAATU0282C AAATU1113G AAATB1585B AAATU0281B AABAL2508C AACAV4176B

No. of theShareholders (I) 0 0 0 1 1 1 1

No. of fully paidup equity sharesheld (IV)

0 0 0 280950 1018050 200 200

No. Of Partlypaid-up equityshares held (V)

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) =(IV)+(V)+ (VI)

0 0 0 280950 1018050 200 200

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

0 0 0 0.15 0.54 0 0

Number of Voting Rights held in each class of securities (IX)

Class eg: X 0 0 0 280950 1018050 200 200

Class eg:y

Total 0 0 0 280950 1018050 200 200

Total as a % ofTotal Votingrights

0 0 0 0.15 0.54 0 0

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

Page 11: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , asa % assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

0 0 0 0.15 0.54 0 0

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of Shares pledged or otherwise encumbered (XIII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

0 0 0 280950 1018050 200 200

Reason for not providing PAN

Reason for notproviding PAN

Shareholder type PromoterGroup

PromoterGroup

PromoterGroup

PromoterGroup

PromoterGroup

PromoterGroup

PromoterGroup

Any Other (specify)

Searial No. 15 16 17 18 19

Category Trusts Trusts Trusts Trusts Partnership Firms Click here to goback

Name of theShareholders (I) Laksh Trust Gallup Trust Grace Star

Trust Satori Trust Viramya PacklightLLP

PAN (II) AABTL5801B AACTG8294J AACTG8296L AATTS7468K AAOFV5056H Total

No. of theShareholders (I) 1 1 1 1 1 14

No. of fully paidup equity shares 100 100 100 100 900 126888718

Page 12: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

held (IV)

No. Of Partlypaid-up equityshares held (V)

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) =(IV)+(V)+ (VI)

100 100 100 100 900 126888718

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

0 0 0 0 0 67.31

Number of Voting Rights held in each class of securities (IX)

Class eg: X 100 100 100 100 900 126888718

Class eg:y

Total 100 100 100 100 900 126888718

Total as a % ofTotal Voting rights 0 0 0 0 0 67.31

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

0 0 0 0 0 67.31

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of Shares pledged or otherwise encumbered (XIII)

Page 13: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

100 100 100 100 900 126888718

Reason for not providing PAN

Reason for notproviding PAN

Shareholder type PromoterGroup

PromoterGroup Promoter Group Promoter

Group Promoter Group

Individuals (NonResident Individuals/ Foreign Individuals)

Searial No. 1 2

Name of theShareholders (I) Udit Chirayu Amin Tishya Udit Amin Click here to go back

PAN (II) ACKPA4056E AWQPS9820A Total

No. of fully paidup equity sharesheld (IV)

1006980 0 1006980

No. Of Partlypaid-up equityshares held (V)

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) =(IV)+(V)+ (VI)

1006980 0 1006980

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

0.53 0 0.53

Number of Voting Rights held in each class of securities (IX)

Class eg: X 1006980 0 1006980

Class eg:y

Total 1006980 0 1006980

Total as a % ofTotal Voting rights 0.53 0 0.53

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of Shares

Page 14: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

UnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

0.53 0 0.53

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of Shares pledged or otherwise encumbered (XIII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

1006980 0 1006980

Reason for not providing PAN

Reason for notproviding PAN

Shareholder type Promoter Group Promoter Group

Mutual Funds

Searial No. 1

Name of theShareholders (I) ICICI Prudential Mutual Fund Click here to go back

PAN (II) AAAAI0038F Total

No. of fully paidup equity sharesheld (IV)

5933746 5933746

No. Of Partlypaid-up equityshares held (V)

No. Of sharesunderlyingDepository

Page 15: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

Receipts (VI)

Total nos. sharesheld (VII) =(IV)+(V)+ (VI)

5933746 5933746

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

3.15 3.15

Number of Voting Rights held in each class of securities (IX)

Class eg: X 5933746 5933746

Class eg:y

Total 5933746 5933746

Total as a % ofTotal Voting rights 3.15 3.15

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

3.15 3.15

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

5933746 5933746

Reason for not providing PAN

Reason for notproviding PAN

Page 16: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

Foreign Portfolio Investors

Searial No. 1 2 3

Name of theShareholders (I) Matthews India Fund Cresta Fund Ltd Elara India Opportunities Fund Limited Click here to go back

PAN (II) AABTM6157F AADCC2634A AABCE6307N Total

No. of fully paidup equity sharesheld (IV)

4147557 2556286 2330000 9033843

No. Of Partlypaid-up equityshares held (V)

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) =(IV)+(V)+ (VI)

4147557 2556286 2330000 9033843

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

2.2 1.36 1.24 4.79

Number of Voting Rights held in each class of securities (IX)

Class eg: X 4147557 2556286 2330000 9033843

Class eg:y

Total 4147557 2556286 2330000 9033843

Total as a % ofTotal Voting rights 2.2 1.36 1.24 4.79

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage of 2.2 1.36 1.24 4.79

Page 17: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

diluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

4147557 2556286 2330000 9033843

Reason for not providing PAN

Reason for notproviding PAN

Insurance Companies

Searial No. 1

Name of theShareholders (I) HDFC Life Insurance Company Limited Click here to go back

PAN (II) AAACH8755L Total

No. of fully paidup equity sharesheld (IV)

1947910 1947910

No. Of Partlypaid-up equityshares held (V)

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) =(IV)+(V)+ (VI)

1947910 1947910

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

1.03 1.03

Number of Voting Rights held in each class of securities (IX)

Class eg: X 1947910 1947910

Class eg:y

Total 1947910 1947910

Total as a % ofTotal Voting rights 1.03 1.03

No. Of SharesUnderlyingOutstanding

Page 18: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

convertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

1.03 1.03

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

1947910 1947910

Reason for not providing PAN

Reason for notproviding PAN

Any Other (specify)

Searial No. 1

Category Other

Category / Morethan 1 percentage Category Click here to go back

Name of theShareholders (I) Foreign Bank

PAN (II) Total

No. of theShareholders (I) 1 1

No. of fully paidup equity sharesheld (IV)

3250 3250

No. Of Partlypaid-up equityshares held (V)

Page 19: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) =(IV)+(V)+ (VI)

3250 3250

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

0 0

Number of Voting Rights held in each class of securities (IX)

Class eg: X 3250 3250

Class eg:y

Total 3250 3250

Total as a % ofTotal Voting rights 0 0

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities andWarrants (X)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

0 0

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

3250 3250

Reason for not providing PAN

Reason for not

Page 20: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

providing PAN

Any Other (specify)

Searial No. 1 2 3 4 5 6 7

Category Trusts HUF Non-Resident Indian(NRI)

Unclaimed or Suspense orEscrow Account IEPF Clearing

MembersBodiesCorporate

Category / Morethan 1 percentage Category Category Category Category Category Category Category

Name of theShareholders (I)

PAN (II)

No. of theShareholders (I) 4 718 908 1 1 65 282

No. of fully paidup equity sharesheld (IV)

9150 345360 455351 146993 1100009 15140 474409

No. Of Partlypaid-up equityshares held (V)

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) =(IV)+(V)+ (VI)

9150 345360 455351 146993 1100009 15140 474409

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

0 0.18 0.24 0.08 0.58 0.01 0.25

Number of Voting Rights held in each class of securities (IX)

Class eg: X 9150 345360 455351 146993 1100009 15140 474409

Class eg:y

Total 9150 345360 455351 146993 1100009 15140 474409

Total as a % ofTotal Voting rights 0 0.18 0.24 0.08 0.58 0.01 0.25

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstanding

Page 21: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

convertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

0 0.18 0.24 0.08 0.58 0.01 0.25

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

6300 345360 454676 146993 1100009 15140 464409

Reason for not providing PAN

Reason for notproviding PAN

Any Other (specify)

Searial No. 8

Category Foreign Portfolio Investor (Category - III)

Category / Morethan 1 percentage Category

Name of theShareholders (I) Click here to go back

PAN (II) Total

No. of theShareholders (I) 1 1980

No. of fully paidup equity sharesheld (IV)

100 2546512

No. Of Partlypaid-up equityshares held (V)

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) =(IV)+(V)+ (VI)

100 2546512

Shareholding as a% of total no. of

Page 22: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

shares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

0 1.34

Number of Voting Rights held in each class of securities (IX)

Class eg: X 100 2546512

Class eg:y

Total 100 2546512

Total as a % ofTotal Voting rights 0 1.34

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

0 1.34

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

100 2532987

Reason for not providing PAN

Reason for notproviding PAN

Details of Shares which remain unclaimed for Public

SearialNo.

Number ofshareholders

Outstanding shares held in demat orunclaimed suspense account

voting rightswhich are frozen

Disclosure of notes on shares which remainunclaimed for public shareholders

Page 23: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

1 1 146993 146993 Textual Information(1)

Text Block

Textual Information(1) As on 30th September, 2019 there are 321 shareholders whose equity shares are lying in UnclaimedSuspense Account and hence remain unclaimed.

significant beneficial owners

Sr.No.

Details of the SBO Details of the registered owner Details of holding/ exercise of right of the SBO inthe reporting company, whether direct or indirect*: Date of

creation /acquisitionofsignificantbeneficialinterest

Name PAN

PassportNo. incase ofaforeignnational

Nationality

Nationality(Applicablein case ofAny otheris selected)

Name PAN

PassportNo. incase ofaforeignnational

Nationality

Nationality(Applicablein case ofAny otheris selected)

Whether by virtue of:

Shares Votingrights

Rights ondistributabledividend orany otherdistribution

Exerciseofcontrol

Exerciseofsignificantinfluence

1

Mr.ChirayuRamanbhaiAmin

ABMPA5729P India AlembicLimited AABCA7950P India 29.47 No No 22-06-2010

2

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaNirayuPrivateLimited

AAACN7427K India 37.15 No No 15-04-2011

3

Mr.ChirayuRamanbhaiAmin

ABMPA5729P India PaushakLimited AAACD5006G India 0.0005 No No 15-04-2011

4

Mr.ChirayuRamanbhaiAmin

ABMPA5729P India

BhailalAminGeneralHospital

AAATB1585B India 0.15 No No 03-04-2019

5

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaUdayEducationSociety

AAATU0281B India 0.54 No No 03-04-2019

6

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaLaburnumFamilyTrust

AABAL2508C India 0 No No 30-03-2017

7

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaVirsadFamilyTrust

AACAV4176B India 0 No No 30-03-2017

8

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaViramyaPacklightLLP

AAOFV5056H India 0.0005 No No 15-04-2011

9

Mr.ChirayuRamanbhai ABMPA5729P India

MalikaChirayuAmin

ABMPA5730G India 1.5944 No No 15-04-2011

Page 24: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

Amin

10

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaPranavChirayuAmin

ABMPA5731H India 0.5357 No No 15-04-2011

11

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaShaunakChirayuAmin

ABJPA6783G India 0.5342 No No 15-04-2011

12

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaInaayaShaunakAmin

BHYPA9184K India 0.0159 No No 20-05-2014

13

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaNaintaraShaunakAmin

ARXPA0076E India 0.0159 No No 15-04-2011

14

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaRanvirPranavAmin

APDPA2105A India 0.0159 No No 15-04-2011

15

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaSamiraPranavAmin

AIPPA9819C India 0.0159 No No 15-04-2011

16

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaUditChirayuAmin

ACKPA4056E India 0.5342 No No 15-04-2011

17

Mr.ChirayuRamanbhaiAmin

ABMPA5729P India

ChirayuRamanbhaiAmin -HUF

ABMPA5729P India 0.57 No No 15-04-2011

18

Mr.ChirayuRamanbhaiAmin

ABMPA5729P India Laksh Trust AABTL5801B India 0 No No 25-09-2019

19

Mr.ChirayuRamanbhaiAmin

ABMPA5729P India GallupTrust AACTG8294J India 0 No No 25-09-2019

20

Mr.ChirayuRamanbhaiAmin

ABMPA5729P India Grace StarTrust AACTG8296L India 0 No No 25-09-2019

21

Mr.ChirayuRamanbhaiAmin

ABMPA5729P India Satori Trust AATTS7468K India 0 No No 25-09-2019

22

Mr.ChirayuRamanbhaiAmin

ABMPA5729P IndiaShrenoPublicationsLimited

AAFCA4386B India 0 No No 25-09-2019

23

Mr.ChirayuRamanbhai ABMPA5729P India

AlembicCityLimited

AABCA9411F India 0 No No 25-09-2019

Page 25: General information about company - Alembic Pharmaceuticals · 2019-10-12 · General information about company Scrip code 533573 NSE Symbol APLLTD MSEI Symbol NOTLISTED ... 42214

file:///E|/DATA%20E/Charandeep/Sheetals%20Documents/APL/Stock%20Exchange/SHP/30.09.2019/asaS.html[11-10-2019 18:22:22]

Amin

Total: 0 71.1431 0